Basics |
89bio, Inc. Common Stock
|
IPO Date: |
November 19, 2021 |
Sector: |
Healthcare |
Industry: |
Biotech |
Market Cap: |
$1.53B |
Activated in VL: |
True |
Average Daily Range |
Avg Daily Range: |
$0.38 | 3.45%
|
Avg Daily Range (30 D): |
$0.21 | 2.10%
|
Avg Daily Range (90 D): |
$0.30 | 3.81%
|
Institutional Daily Volume |
Avg Daily Volume: |
.82M |
Avg Daily Volume (30 D): |
1.51M |
Avg Daily Volume (90 D): |
1.64M |
Trade Size |
Avg Trade Size (Sh.): |
95 |
Avg Trade Size (Sh.) (30 D): |
88 |
Avg Trade Size (Sh.) (90 D): |
88 |
Institutional Trades |
Total Inst.Trades: |
1,201 |
Avg Inst. Trade: |
$2.06M |
Avg Inst. Trade (30 D): |
$2.22M |
Avg Inst. Trade (90 D): |
$2.13M |
Avg Inst. Trade Volume: |
.19M |
Avg Inst. Trades (Per Day): |
1 |
Market Closing Trades |
Avg Closing Trade: |
$2.47M |
Avg Closing Trade (30 D): |
$2.72M |
Avg Closing Trade (90 D): |
$2.43M |
Avg Closing Volume: |
221.03K |
|
|
Financials |
|
TTM |
Q1 2025 |
Q3 2024 |
Basic EPS
|
|
$-.49
|
$-1.39
|
Diluted EPS
|
|
$-.49
|
$-1.39
|
Revenue
|
$
|
$ M
|
$ M
|
Gross Profit
|
$
|
$
|
$
|
Net Income / Loss
|
$
|
$ -71.28M
|
$ -149.07M
|
Operating Income / Loss
|
$
|
$ -75.91M
|
$ -151.94M
|
Cost of Revenue
|
$
|
$
|
$
|
Net Cash Flow
|
$
|
$ 189.34M
|
$ -120.81M
|
PE Ratio
|
|
|
|
|
|
|